Humacyte Investors
Humacyte is a venture capital fund based in Morrisville, North Carolina, established in 2004 The firm specializes in investing in innovative healthcare technologies and regenerative medicine With a significant investment scale of $70 million, Humacyte focuses on advancing the development of human acellular tissue products The fund aims to improve patient outcomes through its commitment to supporting groundbreaking solutions in the medical field Humacytes strategic investments reflect its dedication to fostering innovation and enhancing healthcare delivery
Investors
%20.jpg)
%20.jpg)
%20.jpg)
%20.jpg)
Connections from
Founded Date:
2004
Last Funding Type:
Reverse Merger
Headquarters:
USA
Investors Number:
9
Technology:
Specific disorder-related
Employee Number:
101-250
Industry:
FemTech
Estimated Revenue:
$10-50 Mn
Last Funding Date:
17.02.2021
Funding Status:
Private investment in public equity(PIPE)
Investor Type:
Venture Capital Funds
Total Funding:
$400 000 000